FAM90A20 (Gene)

Entrez:728430

Description:family with sequence similarity 90 member A20

FAM90A20 belongs to subfamily II of the primate-specific FAM90A gene family, which originated from multiple duplications and rearrangements (Bosch et al., 2007 [PubMed 17684299]). For background information on the FAM90A gene family, as well as information on the evolution of FAM90A genes, see FAM90A1 (MIM 613041).[supplied by OMIM, Oct 2009]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View FAM90A20's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with FAM90A20.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using FAM90A20.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for FAM90A20.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with FAM90A20.

Results found

Linked to

	Label	Description
	GSE226285 3 V 0 GLUTATHIONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE187006 3 V 2 VALPROIC ACID HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE169617 azacitidine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE169617 1 V 2 AZACITIDINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE174745 dopamine neuron 1 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE187006 0 V 1 VALPROIC ACID HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE203579 GSE203581 adenosine 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE145285 PRMT5 p53 inhibition RNA Messenger 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE219154 aspirin 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE219154 4 V 2 ASPIRIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

GSE226285 3 V 0 GLUTATHIONE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE187006 3 V 2 VALPROIC ACID HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE169617 azacitidine 1 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE169617 1 V 2 AZACITIDINE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE174745 dopamine neuron 1 v 8 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE187006 0 V 1 VALPROIC ACID HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE203579 GSE203581 adenosine 2 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE145285 PRMT5 p53 inhibition RNA Messenger 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE219154 aspirin 4 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE219154 4 V 2 ASPIRIN HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.